
The Power of Precision Medicine is Exemplified by Tempus
For some patients, a key step to finding their best…

Helping Cancer Patients Access their Own Health Data
For many cancer patients, the ability to access one’s…

How I Cope with the Tsunami of Cancer and COVID-19 Info
Oncologists worldwide face the challenge of staying on top…

How the Coronavirus Pandemic Impacts Cancer Care: Our Survey Results
The ongoing COVID-19 pandemic presents unprecedented challenges…

The Challenges of Using Artificial Intelligence to Improve Cancer Treatment
In a previous post, CureMatch co-founder Razelle Kurzrock,…

How to Beat COVID-19 with Real-Time, Real-World Data
As the COVID-19 pandemic continues, researchers around the world…

What Sets Cancer Commons Apart?
Cancer Commons is a patient-centric, nonprofit network of…

Facilitating Access to Treatment for Children with Brain Cancer
A Q&A with Leslie Jared, RN, MSN, Nurse Navigator at…

Using Artificial Intelligence to Match Combination Targeted Therapies in Oncology
A Q&A with Razelle Kurzrock, MD, Director of the Center for…

Comprehensive Molecular Testing Needed for Stage IV Lung Cancer
A Q&A with David Spigel, MD, Chief Scientific Officer, Director…

Weathering the Perfect Storm of the Vaping Threat
A Q&A with Alan Blum, MD, who founded the Center for the…

Using Molecular Testing to Guide Treatment for Advanced Colorectal Cancer
A Q&A with Kalpana Kannan, PhD, former Scientist at Cancer…

Emphasizing Oncogeriatrics
A Q&A with Nicolò Matteo Luca Battisti, MD, Medical Oncologist…

Fixed and Variable Factors that Impact a Brain Tumor Patient’s Prognosis
A Q&A with Burt Nabors, MD, Professor and Director of the…

How to Treat Uveal Melanoma that Recurs in the Liver?
A Q&A with Emma Shtivelman, PhD, Chief Scientist at Cancer…

The Importance of Brain Tumor-Initiating Cells in Glioblastoma
A Q&A with Anita Hjelmeland, PhD, Associate Professor of…

Navigating Pancreatic Cancer—The Basics
A Q&A with Lola Rahib, PhD, Lead Scientist, Pancreas Cancer,…


Serious Caveats in Screening for Pancreatic Cancer
A Q&A with Rama Gullapalli, MD, PhD; a a physician-scientist…

Encouraging and Paying for Clinical Trials, Right to Try, and Expanded Access: Part Three
A Q&A with Mark Shapiro, PhD,Vice President of Clinical…